Vaccination is enough, there is no person to take, the administration of problems with antidote in India

There is no shortage of vaccines, but recipients are not coming forward out of fear. The opposite picture of Europe is in India. Because, many people think that the third phase trial of Corona vaccine of Bharat Biotech has not ended properly. Success information has not been made public. So fear, if anything happens if you get vaccinated!

 In India, it has been announced that first-line Corona fighters will be vaccinated. Two vaccines have been approved. Covishield of Serum Institute and Covaxin of Bharat Biotech. The process of giving two vaccines has started. Many cannot trust the India Biotech vaccine. Binod Kumar, a doctor at the Institute of Medical Sciences in Patna, said 40 per cent of doctors wanted to wait. "There is no point in running a coroner's vaccine trial on us (health workers) when the number of health workers in India is so low," he said. That is not happening. As of Monday, 2 million people had been vaccinated so far. In Madhya Pradesh, 75 per cent of the target people have been vaccinated till January 21. As of January 23, the percentage of vaccinated in Bihar was 51.7. As of January 19, 55 per cent of the target has been vaccinated in Rajasthan. The southern state of Tamil Nadu has 54 per cent. In Tamil Nadu, covacin and covishield accounted for 23 per cent of those registered for covacin vaccine, compared to 57 per cent for serum institute covishield.

 The government has already declared two vaccines safe. Many people think that the third phase of India Biotech trial has not taken place, it is being applied to the body of health workers like a trial. But such fear is at work all over the world, but it is not. Apart from India, Japan, China and Brazil are facing this problem. But in America and Europe, the picture is the opposite. There are people who get vaccinated, but there is not enough vaccine supply. That is why Britain, Belgium and Saudi Arabia want to buy vaccines from India.

 Adarsh ​​Pratap Singh, a member of the AIIMS Medical Association in New Delhi, said, "Multiple organizations like ours are not sure about the use of covacin. The government should come out with evidence. It's a great way to get acquainted (gain, obtain) with the world around you.

 Krishna Ella, head of Bharat Biotech, said the vaccine was suspected to be a 200 per cent transparent clinical trial. The company has a history of developing 17 safe vaccines. So it does not mean to doubt. Union Health Minister Harsh Vardhan has encouraged people to take the vaccine in the same tone. He also blew up rumors about covacin.